Cargando…

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening

OBJECTIVE: To increase awareness of the limitations of high-risk human papillomavirus (hrHPV) laboratory-developed testing (LDT) widely used in US cervical cancer screening. METHODS AND RESULTS: A young woman in her 30s was diagnosed and treated for stage 1B1 cervical squamous cell carcinoma in whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naryshkin, Sonya, Austin, R Marshall
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496968/ https://www.ncbi.nlm.nih.gov/pubmed/23152707 http://dx.doi.org/10.2147/DHPS.S37273

Ejemplares similares

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
por: Nance, Keith V
Publicado: (2013)

Primary cervical screening with high risk human papillomavirus testing: observational study
por: Rebolj, Matejka, et al.
Publicado: (2019)

Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
por: Kim, Mee-seon, et al.
Publicado: (2020)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
por: Gustavsson, Inger, et al.
Publicado: (2019)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Human papillomavirus testing as a primary screening tool for cervical cancer
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Laboratory and clinical aspects of human papillomavirus testing
por: Chan, Paul K.S., et al.
Publicado: (2012)

Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ
por: ANDERSSON, SONIA, et al.
Publicado: (2013)

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
por: Burger, E A, et al.
Publicado: (2012)

Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?
por: Chung, Soo-Ho
Publicado: (2016)

Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
por: Umulisa, M. Chantal, et al.
Publicado: (2018)

Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection
por: Adebamowo, Sally N., et al.
Publicado: (2020)

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
por: Ruan, Guanyu, et al.
Publicado: (2018)

DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort
por: van Leeuwen, Robert W., et al.
Publicado: (2018)

Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial
por: Zhang, Junji, et al.
Publicado: (2020)

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
por: Clavel, C, et al.
Publicado: (2001)

Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States
por: Kaufman, Harvey W, et al.
Publicado: (2020)

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
por: Zhao, Yanxia, et al.
Publicado: (2021)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2021)

Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women
por: Mbulawa, Zizipho Z.A., et al.
Publicado: (2016)

Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population
por: Paynter, Christopher A., et al.
Publicado: (2015)

Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions
por: Clavel, C, et al.
Publicado: (2004)

Improved Rates of Cervical Cancer Screening Among Transmasculine Patients Through Self-Collected Swabs for High-Risk Human Papillomavirus DNA Testing
por: Goldstein, Zil, et al.
Publicado: (2020)

Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas
por: Segura, Marcos Emanuel de Alcântara
Publicado: (2019)

Comparison of the AdvanSure Human Papillomavirus Screening Real-Time PCR, the Abbott RealTime High Risk Human Papillomavirus Test, and the Hybrid Capture Human Papillomavirus DNA Test for the Detection of Human Papillomavirus
por: Hwang, Yusun, et al.
Publicado: (2012)

Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
por: Gupta, Sarah, et al.
Publicado: (2018)

Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
por: Rebolj, Matejka, et al.
Publicado: (2022)

Cervical Human Papillomavirus Screening among Older Women
por: Grainge, Matthew J., et al.
Publicado: (2005)

The psychosexual impact of testing positive for high‐risk cervical human papillomavirus (HPV): A systematic review
por: Bennett, Kirsty F., et al.
Publicado: (2019)

Exploring the psychosexual impact and disclosure experiences of women testing positive for high‐risk cervical human papillomavirus
por: Bennett, Kirsty F., et al.
Publicado: (2022)

Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening
por: Li, Jingran, et al.
Publicado: (2022)

Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing
por: Marchadier, Agathe, et al.
Publicado: (2023)

Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
por: Chadwick, Verity, et al.
Publicado: (2022)

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
por: Kailash, U, et al.
Publicado: (2006)

The role of human papillomavirus testing after treatment for high-grade cervical dysplasia
por: Turner, Taylor B, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ekarl1h02q1eq8u51ff8g0kfph